Data as of Aug 28
| +0.024 / +0.44%|
The 1 analysts offering 12-month price forecasts for Skystar Bio-Pharmaceutical Co have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a -54.71% decrease from the last price of 5.52.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.